Rate per 100,000 Population of Reported Cases* by Age Group - 2009

Disease < 1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60+ Total
AIDS** 2.5 0.0 0.0 2.8 10.9 45.6 83.1 112.7 64.5 19.4 48.8
Amebiasis 0.8 1.8 3.5 3.4 3.1 5.6 7.1 7.7 5.8 2.9 5.1
Babesiosis 0.8 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.7 1.6 0.5
Botulism 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.01
Campylobacteriosis 117.4 47.1 15.0 10.2 10.2 11.5 8.0 4.3 4.9 5.3 11.6
Chlamydia NA NA NA 154.9 3455.4 2379.7 518.1 191.5 68.7 12.8 698.0
Cholera 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.02
Cryptosporidiosis 0.0 1.3 1.2 0.6 0.4 1.5 1.3 1.3 0.6 0.4 1.0
Cyclospora 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.4 0.4 0.2 0.2
Dengue Fever 0.0 0.0 0.2 0.0 0.4 0.5 1.0 5.0 0.8 0.6 0.6
E. Coli O157 0.0 1.3 0.6 0.6 0.0 0.6 0.6 0.2 0.3 0.2 0.4
EHEC*** 0.0 1.8 0.4 0.4 0.4 0.2 0.1 0.1 0.2 0.1 0.3
Ehrlichiosis 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.1 0.8 0.2
Encephalitis (Non-Westnile) 3.3 0.9 2.7 1.2 1.6 1.7 1.8 1.8 1.8 3.6 2.1
Giardiasis 6.6 23.5 16.8 7.0 5.3 11.8 11.8 10.6 7.7 4.4 10.0
Gonorrhea NA NA NA 26.5 495.2 436.1 126.1 69.1 18.1 2.2 129.2
Haemophilus Influenzae 8.3 1.3 0.4 0.0 0.7 0.1 0.5 0.5 1.4 1.9 0.9
Hemolytic Uremic Syndrome 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1
Hepatitis A 0.0 0.7 0.6 0.2 2.7 2.7 1.3 0.8 0.3 0.3 1.1
Hepatitis B - Acute 0.0 0.0 0.0 0.0 0.4 0.4 1.2 1.7 1.6 0.8 0.9
HIV**** 8.3 0.0 0.0 0.8 30.3 100.3 89.8 89.5 52.9 12.8 52.7
Legionellosis 0.0 0.0 0.0 0.0 0.2 0.6 0.7 3.8 4.6 8.1 1.7
Listeriosis 5.8 0.0 0.2 0.0 0.2 0.3 0.5 0.2 0.2 1.1 0.5
Lyme Disease 0.0 4.4 8.5 10.6 7.6 13.2 16.1 14.0 15.8 12.9 12.6
Lymphogranuloma Venereum NA NA NA 0.0 0.2 2.0 2.0 1.7 0.2 0.0 0.9
Malaria 0.8 1.3 2.3 3.0 2.0 2.4 2.4 4.1 3.2 1.1 2.4
Measles 1.7 2.2 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2
Meningitis Aseptic 28.1 2.0 3.5 3.4 4.2 3.9 3.1 3.1 1.7 2.0 3.3
Meningococcal 1.7 0.0 0.0 0.0 0.2 0.3 0.3 0.1 0.3 0.1 0.2
Meningitis Other Bacterial 19.8 0.9 0.2 0.4 0.9 0.4 0.5 0.8 1.1 1.4 1.1
Mumps 4.1 7.5 12.1 41.3 43.7 13.6 3.9 1.7 0.7 1.1 9.6
Pertussis 29.8 1.3 1.9 1.6 0.2 1.0 1.0 0.3 0.3 0.4 1.2
Q Fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.01
RMSF 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.1
Salmonellosis 124.9 62.0 27.2 10.6 11.1 10.6 6.2 7.0 9.4 11.7 15.0
Shigellosis 9.9 18.5 15.6 2.4 1.8 4.7 6.6 4.3 2.1 2.0 5.3
Strep Group A Invasive 3.3 3.1 1.5 0.6 0.5 0.7 1.0 1.0 3.8 6.1 2.3
Strep Pneumonia Invasive 27.3 18.9 3.9 1.4 2.2 3.6 5.4 14.6 15.9 22.3 11.2
Syphilis Early NA NA NA 0.0 14.7 50.7 50.9 49.2 17.0 3.2 26.2
Syphilis Late NA NA NA 0.2 9.6 32.5 35.0 37.9 17.2 13.0 20.8
Toxic Shock Syndrome 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.04
Trichinosis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.01
Tuberculosis 1.7 2.6 1.2 1.2 7.1 12.1 9.8 9.7 11.6 12.7 9.1
Tularemia 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.01
Typhoid Fever 0.0 2.9 1.5 1.0 1.3 0.6 0.6 0.2 0.2 0.1 0.6
Vibrio - Non Cholera 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 0.4 0.4 0.3
VISA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.6 0.2
West Nile Virus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.04
Yersiniosis 2.5 0.4 0.2 0.0 0.2 0.3 0.1 0.0 0.1 0.1 0.2

Footnotes

  • * Based on Diagnosis year
  • ** Based on report year (excludes inmates). Includes all newly-reports AIDS cases regardless of HIV diagnosis date. Provisional, data as of August 5, 2010. County of residence is unknown for 6 cases.
  • *** E.coli non-O157 and not sero-grouped shigatoxin producing infection
  • **** Based on report year (excludes inmates). Includes all newly-reported HIV cases, regardless of concurrent or subsequent AIDS diagnosis. Provisional, data as of August 5, 2010. County of residence is unknown for 16 cases.